Avai Bio (AVAI) Other Accumulated Expenses (2018 - 2026)

Avai Bio (AVAI) has 8 years of Other Accumulated Expenses data on file, last reported at $744420.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Accumulated Expenses rose 45.37% year-over-year to $744420.0; the trailing twelve-month figure through Mar 2026 stood at $744420.0 (up 45.37% YoY), and the FY2026 full-year result was $744420.0, up 45.37% from the prior year.
• Other Accumulated Expenses advanced to $744420.0 in Q1 2026, from $698034.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $744420.0 in Q1 2026 to a low of $2816.0 in Q1 2022.
• A 5-year average of $525787.7 and a median of $631891.0 in 2025 frame the typical range for Other Accumulated Expenses.
• Across the five-year window, Other Accumulated Expenses jumped 8572.51% in 2023 and dropped 0.47% in 2025, its largest moves.
• Tracing AVAI's Other Accumulated Expenses over 5 years: stood at $2816.0 in 2022, then jumped by 8572.51% to $244218.0 in 2023, then jumped by 121.57% to $541123.0 in 2024, then grew by 29.0% to $698034.0 in 2025, then grew by 6.65% to $744420.0 in 2026.
• Business Quant data shows AVAI's Other Accumulated Expenses at $744420.0 in Q1 2026, $698034.0 in Q4 2025, and $700383.0 in Q3 2025.